Toshihide Yamashita Selected Research

oxygen-regulated proteins

1/2003

Induction of mRNAs and proteins for Na/K ATPase alpha1 and beta1 subunits following hypoxia/reoxygenation in astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihide Yamashita Research Topics

Disease

24	Spinal Cord Injuries (Spinal Cord Injury) 08/2022 - 06/2006
14	Inflammation (Inflammations) 01/2022 - 02/2002
8	Pain (Aches) 05/2022 - 09/2005
6	Wounds and Injuries (Trauma) 08/2014 - 08/2006
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 09/2009
4	Stroke (Strokes) 04/2022 - 06/2008
4	Hyperalgesia 01/2019 - 09/2005
4	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 05/2015
3	Chronic Pain 05/2022 - 10/2009
3	Multiple Sclerosis 01/2022 - 04/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2011
3	Neuralgia (Stump Neuralgia) 01/2021 - 02/2014
3	Contusions 01/2021 - 08/2006
3	Gliosis 01/2021 - 12/2009
3	Brain Injuries (Brain Injury) 01/2020 - 09/2009
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2018
3	Hypoxia (Hypoxemia) 11/2011 - 01/2002
3	Wallerian Degeneration 08/2009 - 05/2005
2	Ischemic Stroke 04/2022 - 01/2017
2	Infarction (Infarctions) 04/2022 - 01/2017
2	Cognitive Dysfunction 01/2022 - 10/2018
2	Proteostasis Deficiencies 01/2022 - 01/2020
2	Neuroinflammatory Diseases 01/2020 - 09/2012
2	Hypersensitivity (Allergy) 01/2019 - 09/2005
2	Peripheral Nerve Injuries 01/2019 - 09/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 07/2010
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2018
1	Rabies (Hydrophobia) 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Ischemia 02/2020
1	Disease Progression 01/2020
1	Synucleinopathies 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Prodromal Symptoms 01/2020
1	Encephalomyelitis (Myeloencephalitis) 02/2019
1	Body Weight (Weight, Body) 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
10	rho-Associated KinasesIBA 11/2011 - 05/2005
6	Neutralizing AntibodiesIBA 01/2021 - 12/2008
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2007
4	Therapeutic UsesIBA 01/2022 - 06/2008
3	Chondroitin Sulfate ProteoglycansIBA 01/2021 - 08/2007
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 04/2012
3	neogeninIBA 01/2019 - 10/2008
3	CytokinesIBA 05/2016 - 09/2007
3	Nerve Growth Factor (NGF)IBA 10/2009 - 09/2005
3	Freund's AdjuvantIBA 12/2008 - 09/2005
2	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2018
2	GlycosaminoglycansIBA 01/2022 - 04/2010
2	Leptin ReceptorsIBA 01/2019 - 01/2017
2	LeptinIBA 01/2019 - 01/2017
2	ChemokinesIBA 05/2016 - 08/2015
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2015 - 11/2012
2	Keratan SulfateIBA 11/2011 - 04/2010
2	Oxygen (Dioxygen)IBA 11/2011 - 01/2003
2	JNK Mitogen-Activated Protein KinasesIBA 11/2011 - 09/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2011 - 09/2010
2	fasudil (AT 877)IBA 10/2009 - 08/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009 - 02/2002
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 12/2008 - 05/2006
2	Growth InhibitorsIBA 12/2007 - 08/2006
2	Messenger RNA (mRNA)IBA 01/2003 - 01/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022
1	P-SelectinIBA 04/2022
1	Colchicine FDA LinkGeneric 04/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Lipid Droplet Associated ProteinsIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Oligodendrocyte-Myelin GlycoproteinIBA 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Myelin-Associated GlycoproteinIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 02/2020
1	polyglutamineIBA 01/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	AutoantibodiesIBA 02/2019
1	Interleukin-10 (Interleukin 10)IBA 02/2019
1	AntibodiesIBA 01/2019
1	pexidartinibIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Monoclonal AntibodiesIBA 10/2018
1	ChromatinIBA 10/2018
1	Ivermectin (Mectizan)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018

Therapy/Procedure

7	Therapeutics 05/2022 - 10/2009
3	Transplantation 08/2010 - 10/2009
2	Transcranial Magnetic Stimulation 01/2021 - 01/2019
1	Injections 01/2022
1	Nerve Block (Nerve Blocks) 01/2021
1	Immunotherapy 01/2020
1	Ligation 01/2019